nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—Testosterone—Spironolactone—dilated cardiomyopathy	0.262	1	CrCrCtD
Estradiol—SHBG—Spironolactone—dilated cardiomyopathy	0.146	0.274	CbGbCtD
Estradiol—AR—Spironolactone—dilated cardiomyopathy	0.122	0.229	CbGbCtD
Estradiol—SLC22A11—Furosemide—dilated cardiomyopathy	0.0685	0.129	CbGbCtD
Estradiol—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.0669	0.126	CbGbCtD
Estradiol—SLC22A8—Furosemide—dilated cardiomyopathy	0.0398	0.0748	CbGbCtD
Estradiol—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0267	0.0502	CbGbCtD
Estradiol—ALB—Furosemide—dilated cardiomyopathy	0.0236	0.0444	CbGbCtD
Estradiol—ABCB1—Lisinopril—dilated cardiomyopathy	0.0205	0.0386	CbGbCtD
Estradiol—ABCB1—Spironolactone—dilated cardiomyopathy	0.0181	0.034	CbGbCtD
Estradiol—CYP2C9—cardial valve—dilated cardiomyopathy	0.00565	0.194	CbGeAlD
Estradiol—ESRRB—heart—dilated cardiomyopathy	0.00325	0.111	CbGeAlD
Estradiol—Glucose tolerance decreased—Furosemide—dilated cardiomyopathy	0.00321	0.0308	CcSEcCtD
Estradiol—Glucose tolerance impaired—Furosemide—dilated cardiomyopathy	0.00239	0.0229	CcSEcCtD
Estradiol—GPER1—heart—dilated cardiomyopathy	0.00223	0.0766	CbGeAlD
Estradiol—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.00214	0.0205	CcSEcCtD
Estradiol—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.00201	0.0193	CcSEcCtD
Estradiol—Common cold—Lisinopril—dilated cardiomyopathy	0.00185	0.0177	CcSEcCtD
Estradiol—Incontinence—Furosemide—dilated cardiomyopathy	0.00184	0.0177	CcSEcCtD
Estradiol—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.00182	0.0175	CcSEcCtD
Estradiol—ESRRA—cardiac ventricle—dilated cardiomyopathy	0.00158	0.0542	CbGeAlD
Estradiol—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00154	0.0148	CcSEcCtD
Estradiol—ESRRA—myocardium—dilated cardiomyopathy	0.00149	0.051	CbGeAlD
Estradiol—Breast pain—Spironolactone—dilated cardiomyopathy	0.00136	0.013	CcSEcCtD
Estradiol—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.00135	0.013	CcSEcCtD
Estradiol—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00135	0.0129	CcSEcCtD
Estradiol—Ulcer—Spironolactone—dilated cardiomyopathy	0.00125	0.012	CcSEcCtD
Estradiol—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00109	0.0104	CcSEcCtD
Estradiol—SLCO4A1—cardiac ventricle—dilated cardiomyopathy	0.00107	0.0367	CbGeAlD
Estradiol—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00106	0.0102	CcSEcCtD
Estradiol—Eruption—Furosemide—dilated cardiomyopathy	0.00105	0.01	CcSEcCtD
Estradiol—Leg pain—Lisinopril—dilated cardiomyopathy	0.00105	0.01	CcSEcCtD
Estradiol—ESRRA—heart—dilated cardiomyopathy	0.00104	0.0356	CbGeAlD
Estradiol—SLCO4A1—myocardium—dilated cardiomyopathy	0.00101	0.0345	CbGeAlD
Estradiol—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.000957	0.00918	CcSEcCtD
Estradiol—Thrombosis—Furosemide—dilated cardiomyopathy	0.000909	0.00872	CcSEcCtD
Estradiol—Ear disorder—Lisinopril—dilated cardiomyopathy	0.000894	0.00858	CcSEcCtD
Estradiol—ABCC10—cardiac ventricle—dilated cardiomyopathy	0.000889	0.0305	CbGeAlD
Estradiol—ESRRA—cardiac atrium—dilated cardiomyopathy	0.000888	0.0305	CbGeAlD
Estradiol—Lethargy—Spironolactone—dilated cardiomyopathy	0.000876	0.00841	CcSEcCtD
Estradiol—Blindness—Lisinopril—dilated cardiomyopathy	0.000872	0.00837	CcSEcCtD
Estradiol—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.000793	0.00761	CcSEcCtD
Estradiol—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000773	0.00742	CcSEcCtD
Estradiol—Gastritis—Spironolactone—dilated cardiomyopathy	0.00076	0.00729	CcSEcCtD
Estradiol—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000732	0.00703	CcSEcCtD
Estradiol—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.000703	0.00674	CcSEcCtD
Estradiol—SLCO4A1—heart—dilated cardiomyopathy	0.000703	0.0241	CbGeAlD
Estradiol—Drug interaction—Furosemide—dilated cardiomyopathy	0.000694	0.00666	CcSEcCtD
Estradiol—Hearing impaired—Furosemide—dilated cardiomyopathy	0.000676	0.00649	CcSEcCtD
Estradiol—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.000676	0.00649	CcSEcCtD
Estradiol—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00067	0.00643	CcSEcCtD
Estradiol—AR—cardiac ventricle—dilated cardiomyopathy	0.000662	0.0227	CbGeAlD
Estradiol—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.000652	0.00626	CcSEcCtD
Estradiol—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.000641	0.00615	CcSEcCtD
Estradiol—ESR2—heart—dilated cardiomyopathy	0.000623	0.0214	CbGeAlD
Estradiol—AR—myocardium—dilated cardiomyopathy	0.000623	0.0214	CbGeAlD
Estradiol—Otitis media—Lisinopril—dilated cardiomyopathy	0.00062	0.00595	CcSEcCtD
Estradiol—SLCO4A1—cardiac atrium—dilated cardiomyopathy	0.000601	0.0206	CbGeAlD
Estradiol—AOX1—heart—dilated cardiomyopathy	0.0006	0.0206	CbGeAlD
Estradiol—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000591	0.00567	CcSEcCtD
Estradiol—ABCC10—heart—dilated cardiomyopathy	0.000584	0.02	CbGeAlD
Estradiol—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.000582	0.00559	CcSEcCtD
Estradiol—Urine output increased—Furosemide—dilated cardiomyopathy	0.000582	0.00558	CcSEcCtD
Estradiol—Bladder pain—Furosemide—dilated cardiomyopathy	0.000582	0.00558	CcSEcCtD
Estradiol—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000561	0.00539	CcSEcCtD
Estradiol—Breast pain—Lisinopril—dilated cardiomyopathy	0.000553	0.00531	CcSEcCtD
Estradiol—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000549	0.00527	CcSEcCtD
Estradiol—SLCO2B1—heart—dilated cardiomyopathy	0.000547	0.0188	CbGeAlD
Estradiol—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.000546	0.00524	CcSEcCtD
Estradiol—Accidental injury—Lisinopril—dilated cardiomyopathy	0.000546	0.00524	CcSEcCtD
Estradiol—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000539	0.00518	CcSEcCtD
Estradiol—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000534	0.00513	CcSEcCtD
Estradiol—Viral infection—Lisinopril—dilated cardiomyopathy	0.000534	0.00513	CcSEcCtD
Estradiol—Polyuria—Furosemide—dilated cardiomyopathy	0.000532	0.0051	CcSEcCtD
Estradiol—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000531	0.00509	CcSEcCtD
Estradiol—Swelling—Furosemide—dilated cardiomyopathy	0.000529	0.00508	CcSEcCtD
Estradiol—Cough increased—Lisinopril—dilated cardiomyopathy	0.000527	0.00506	CcSEcCtD
Estradiol—Alopecia—Spironolactone—dilated cardiomyopathy	0.000525	0.00504	CcSEcCtD
Estradiol—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000522	0.00501	CcSEcCtD
Estradiol—Deafness—Furosemide—dilated cardiomyopathy	0.000522	0.00501	CcSEcCtD
Estradiol—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00052	0.00499	CcSEcCtD
Estradiol—AOX1—cardiac atrium—dilated cardiomyopathy	0.000513	0.0176	CbGeAlD
Estradiol—ALB—heart—dilated cardiomyopathy	0.0005	0.0172	CbGeAlD
Estradiol—ABCC10—cardiac atrium—dilated cardiomyopathy	0.000499	0.0171	CbGeAlD
Estradiol—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000497	0.00477	CcSEcCtD
Estradiol—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.000494	0.017	CbGeAlD
Estradiol—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000489	0.00469	CcSEcCtD
Estradiol—Neck pain—Lisinopril—dilated cardiomyopathy	0.000489	0.00469	CcSEcCtD
Estradiol—Purpura—Furosemide—dilated cardiomyopathy	0.000485	0.00465	CcSEcCtD
Estradiol—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000483	0.00463	CcSEcCtD
Estradiol—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000483	0.00463	CcSEcCtD
Estradiol—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00048	0.0046	CcSEcCtD
Estradiol—Lethargy—Furosemide—dilated cardiomyopathy	0.000477	0.00457	CcSEcCtD
Estradiol—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000472	0.00453	CcSEcCtD
Estradiol—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000469	0.0045	CcSEcCtD
Estradiol—Malaise—Spironolactone—dilated cardiomyopathy	0.000466	0.00447	CcSEcCtD
Estradiol—Cystitis—Lisinopril—dilated cardiomyopathy	0.000466	0.00447	CcSEcCtD
Estradiol—CYP1B1—heart—dilated cardiomyopathy	0.000459	0.0157	CbGeAlD
Estradiol—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000458	0.0044	CcSEcCtD
Estradiol—Irritability—Furosemide—dilated cardiomyopathy	0.000446	0.00428	CcSEcCtD
Estradiol—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000436	0.00419	CcSEcCtD
Estradiol—Discomfort—Spironolactone—dilated cardiomyopathy	0.000435	0.00417	CcSEcCtD
Estradiol—AR—heart—dilated cardiomyopathy	0.000435	0.0149	CbGeAlD
Estradiol—ESR1—heart—dilated cardiomyopathy	0.000427	0.0146	CbGeAlD
Estradiol—Confusional state—Spironolactone—dilated cardiomyopathy	0.000425	0.00408	CcSEcCtD
Estradiol—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000423	0.00406	CcSEcCtD
Estradiol—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000422	0.00405	CcSEcCtD
Estradiol—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000421	0.00404	CcSEcCtD
Estradiol—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000406	0.0039	CcSEcCtD
Estradiol—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000401	0.00385	CcSEcCtD
Estradiol—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000396	0.0038	CcSEcCtD
Estradiol—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000395	0.00379	CcSEcCtD
Estradiol—Eczema—Lisinopril—dilated cardiomyopathy	0.00039	0.00374	CcSEcCtD
Estradiol—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000385	0.00369	CcSEcCtD
Estradiol—Injury—Lisinopril—dilated cardiomyopathy	0.000381	0.00366	CcSEcCtD
Estradiol—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000378	0.00363	CcSEcCtD
Estradiol—Somnolence—Spironolactone—dilated cardiomyopathy	0.000375	0.0036	CcSEcCtD
Estradiol—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000373	0.00358	CcSEcCtD
Estradiol—AR—cardiac atrium—dilated cardiomyopathy	0.000372	0.0128	CbGeAlD
Estradiol—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000368	0.00354	CcSEcCtD
Estradiol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000364	0.0035	CcSEcCtD
Estradiol—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000364	0.00349	CcSEcCtD
Estradiol—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000362	0.00347	CcSEcCtD
Estradiol—Arthritis—Lisinopril—dilated cardiomyopathy	0.000361	0.00346	CcSEcCtD
Estradiol—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000358	0.00343	CcSEcCtD
Estradiol—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00035	0.00336	CcSEcCtD
Estradiol—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00035	0.00336	CcSEcCtD
Estradiol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000348	0.00334	CcSEcCtD
Estradiol—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000348	0.00334	CcSEcCtD
Estradiol—ABCG2—heart—dilated cardiomyopathy	0.000342	0.0117	CbGeAlD
Estradiol—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00034	0.00327	CcSEcCtD
Estradiol—Face oedema—Lisinopril—dilated cardiomyopathy	0.000338	0.00325	CcSEcCtD
Estradiol—Urticaria—Spironolactone—dilated cardiomyopathy	0.000335	0.00322	CcSEcCtD
Estradiol—Irritability—Lisinopril—dilated cardiomyopathy	0.000334	0.00321	CcSEcCtD
Estradiol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000334	0.0032	CcSEcCtD
Estradiol—CYP1A1—heart—dilated cardiomyopathy	0.000324	0.0111	CbGeAlD
Estradiol—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000319	0.00306	CcSEcCtD
Estradiol—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000317	0.00304	CcSEcCtD
Estradiol—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000317	0.00304	CcSEcCtD
Estradiol—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000316	0.00303	CcSEcCtD
Estradiol—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000313	0.00301	CcSEcCtD
Estradiol—CYP2C9—heart—dilated cardiomyopathy	0.000312	0.0107	CbGeAlD
Estradiol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000311	0.00299	CcSEcCtD
Estradiol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000311	0.00298	CcSEcCtD
Estradiol—Gastritis—Lisinopril—dilated cardiomyopathy	0.00031	0.00298	CcSEcCtD
Estradiol—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000305	0.00293	CcSEcCtD
Estradiol—Asthma—Lisinopril—dilated cardiomyopathy	0.000303	0.00291	CcSEcCtD
Estradiol—Influenza—Lisinopril—dilated cardiomyopathy	0.000303	0.00291	CcSEcCtD
Estradiol—Eye disorder—Furosemide—dilated cardiomyopathy	0.000302	0.0029	CcSEcCtD
Estradiol—Tinnitus—Furosemide—dilated cardiomyopathy	0.000301	0.00289	CcSEcCtD
Estradiol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000298	0.00286	CcSEcCtD
Estradiol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000298	0.00286	CcSEcCtD
Estradiol—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000297	0.00285	CcSEcCtD
Estradiol—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000295	0.00283	CcSEcCtD
Estradiol—Angiopathy—Furosemide—dilated cardiomyopathy	0.000293	0.00281	CcSEcCtD
Estradiol—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000292	0.0028	CcSEcCtD
Estradiol—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000291	0.0028	CcSEcCtD
Estradiol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000289	0.00277	CcSEcCtD
Estradiol—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000281	0.0027	CcSEcCtD
Estradiol—Malnutrition—Furosemide—dilated cardiomyopathy	0.000281	0.0027	CcSEcCtD
Estradiol—Erythema—Furosemide—dilated cardiomyopathy	0.000281	0.0027	CcSEcCtD
Estradiol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000279	0.00268	CcSEcCtD
Estradiol—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000278	0.00952	CbGeAlD
Estradiol—Flatulence—Furosemide—dilated cardiomyopathy	0.000277	0.00266	CcSEcCtD
Estradiol—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000276	0.00265	CcSEcCtD
Estradiol—Weight increased—Lisinopril—dilated cardiomyopathy	0.000276	0.00265	CcSEcCtD
Estradiol—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000275	0.00264	CcSEcCtD
Estradiol—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000274	0.00263	CcSEcCtD
Estradiol—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000273	0.00262	CcSEcCtD
Estradiol—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000272	0.00261	CcSEcCtD
Estradiol—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00027	0.00259	CcSEcCtD
Estradiol—Depression—Lisinopril—dilated cardiomyopathy	0.000269	0.00258	CcSEcCtD
Estradiol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000268	0.00257	CcSEcCtD
Estradiol—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000266	0.00255	CcSEcCtD
Estradiol—Rash—Spironolactone—dilated cardiomyopathy	0.000266	0.00255	CcSEcCtD
Estradiol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000266	0.00255	CcSEcCtD
Estradiol—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000265	0.00254	CcSEcCtD
Estradiol—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000265	0.00254	CcSEcCtD
Estradiol—Headache—Spironolactone—dilated cardiomyopathy	0.000264	0.00254	CcSEcCtD
Estradiol—Jaundice—Lisinopril—dilated cardiomyopathy	0.000263	0.00253	CcSEcCtD
Estradiol—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000262	0.00252	CcSEcCtD
Estradiol—Agitation—Furosemide—dilated cardiomyopathy	0.000258	0.00248	CcSEcCtD
Estradiol—Haematuria—Lisinopril—dilated cardiomyopathy	0.000257	0.00247	CcSEcCtD
Estradiol—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000255	0.00245	CcSEcCtD
Estradiol—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000255	0.00244	CcSEcCtD
Estradiol—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000253	0.00243	CcSEcCtD
Estradiol—Vertigo—Furosemide—dilated cardiomyopathy	0.000253	0.00242	CcSEcCtD
Estradiol—Nausea—Spironolactone—dilated cardiomyopathy	0.000251	0.0024	CcSEcCtD
Estradiol—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000243	0.00233	CcSEcCtD
Estradiol—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000242	0.00233	CcSEcCtD
Estradiol—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000241	0.00231	CcSEcCtD
Estradiol—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000239	0.0023	CcSEcCtD
Estradiol—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000239	0.00229	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000238	0.00228	CcSEcCtD
Estradiol—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000238	0.00228	CcSEcCtD
Estradiol—Dry mouth—Furosemide—dilated cardiomyopathy	0.000234	0.00225	CcSEcCtD
Estradiol—Confusional state—Furosemide—dilated cardiomyopathy	0.000231	0.00222	CcSEcCtD
Estradiol—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00023	0.0022	CcSEcCtD
Estradiol—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000229	0.0022	CcSEcCtD
Estradiol—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000226	0.00217	CcSEcCtD
Estradiol—Shock—Furosemide—dilated cardiomyopathy	0.000226	0.00217	CcSEcCtD
Estradiol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000225	0.00216	CcSEcCtD
Estradiol—Flushing—Lisinopril—dilated cardiomyopathy	0.000225	0.00216	CcSEcCtD
Estradiol—Skin disorder—Furosemide—dilated cardiomyopathy	0.000223	0.00214	CcSEcCtD
Estradiol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000222	0.00213	CcSEcCtD
Estradiol—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00022	0.00211	CcSEcCtD
Estradiol—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000218	0.0021	CcSEcCtD
Estradiol—Chills—Lisinopril—dilated cardiomyopathy	0.000218	0.00209	CcSEcCtD
Estradiol—Alopecia—Lisinopril—dilated cardiomyopathy	0.000214	0.00206	CcSEcCtD
Estradiol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000212	0.00204	CcSEcCtD
Estradiol—Erythema—Lisinopril—dilated cardiomyopathy	0.000211	0.00203	CcSEcCtD
Estradiol—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000211	0.00203	CcSEcCtD
Estradiol—Flatulence—Lisinopril—dilated cardiomyopathy	0.000208	0.002	CcSEcCtD
Estradiol—Tension—Lisinopril—dilated cardiomyopathy	0.000207	0.00199	CcSEcCtD
Estradiol—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000207	0.00198	CcSEcCtD
Estradiol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000206	0.00198	CcSEcCtD
Estradiol—Nervousness—Lisinopril—dilated cardiomyopathy	0.000205	0.00197	CcSEcCtD
Estradiol—Back pain—Lisinopril—dilated cardiomyopathy	0.000204	0.00196	CcSEcCtD
Estradiol—Somnolence—Furosemide—dilated cardiomyopathy	0.000204	0.00196	CcSEcCtD
Estradiol—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000203	0.00195	CcSEcCtD
Estradiol—Decreased appetite—Furosemide—dilated cardiomyopathy	0.0002	0.00191	CcSEcCtD
Estradiol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000198	0.0019	CcSEcCtD
Estradiol—Fatigue—Furosemide—dilated cardiomyopathy	0.000198	0.0019	CcSEcCtD
Estradiol—Tremor—Lisinopril—dilated cardiomyopathy	0.000198	0.0019	CcSEcCtD
Estradiol—Pain—Furosemide—dilated cardiomyopathy	0.000196	0.00188	CcSEcCtD
Estradiol—Constipation—Furosemide—dilated cardiomyopathy	0.000196	0.00188	CcSEcCtD
Estradiol—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000196	0.00188	CcSEcCtD
Estradiol—Angioedema—Lisinopril—dilated cardiomyopathy	0.000193	0.00185	CcSEcCtD
Estradiol—Malaise—Lisinopril—dilated cardiomyopathy	0.00019	0.00183	CcSEcCtD
Estradiol—Vertigo—Lisinopril—dilated cardiomyopathy	0.00019	0.00182	CcSEcCtD
Estradiol—Syncope—Lisinopril—dilated cardiomyopathy	0.000189	0.00182	CcSEcCtD
Estradiol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000189	0.00182	CcSEcCtD
Estradiol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000188	0.0018	CcSEcCtD
Estradiol—Palpitations—Lisinopril—dilated cardiomyopathy	0.000186	0.00179	CcSEcCtD
Estradiol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000185	0.00178	CcSEcCtD
Estradiol—Cough—Lisinopril—dilated cardiomyopathy	0.000184	0.00177	CcSEcCtD
Estradiol—Urticaria—Furosemide—dilated cardiomyopathy	0.000182	0.00175	CcSEcCtD
Estradiol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000181	0.00174	CcSEcCtD
Estradiol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000181	0.00174	CcSEcCtD
Estradiol—Chest pain—Lisinopril—dilated cardiomyopathy	0.00018	0.00172	CcSEcCtD
Estradiol—Myalgia—Lisinopril—dilated cardiomyopathy	0.00018	0.00172	CcSEcCtD
Estradiol—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00018	0.00172	CcSEcCtD
Estradiol—Anxiety—Lisinopril—dilated cardiomyopathy	0.000179	0.00172	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000178	0.00171	CcSEcCtD
Estradiol—Discomfort—Lisinopril—dilated cardiomyopathy	0.000178	0.0017	CcSEcCtD
Estradiol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000176	0.00169	CcSEcCtD
Estradiol—Confusional state—Lisinopril—dilated cardiomyopathy	0.000174	0.00167	CcSEcCtD
Estradiol—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000172	0.00165	CcSEcCtD
Estradiol—Oedema—Lisinopril—dilated cardiomyopathy	0.000172	0.00165	CcSEcCtD
Estradiol—Infection—Lisinopril—dilated cardiomyopathy	0.000171	0.00164	CcSEcCtD
Estradiol—Shock—Lisinopril—dilated cardiomyopathy	0.000169	0.00163	CcSEcCtD
Estradiol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000169	0.00162	CcSEcCtD
Estradiol—ABCB1—heart—dilated cardiomyopathy	0.000169	0.00578	CbGeAlD
Estradiol—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000168	0.00161	CcSEcCtD
Estradiol—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000167	0.00161	CcSEcCtD
Estradiol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000166	0.0016	CcSEcCtD
Estradiol—Asthenia—Furosemide—dilated cardiomyopathy	0.000165	0.00158	CcSEcCtD
Estradiol—Pruritus—Furosemide—dilated cardiomyopathy	0.000162	0.00156	CcSEcCtD
Estradiol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000157	0.00151	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000157	0.00151	CcSEcCtD
Estradiol—Insomnia—Lisinopril—dilated cardiomyopathy	0.000156	0.00149	CcSEcCtD
Estradiol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000155	0.00148	CcSEcCtD
Estradiol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000154	0.00147	CcSEcCtD
Estradiol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000153	0.00147	CcSEcCtD
Estradiol—Dizziness—Furosemide—dilated cardiomyopathy	0.000152	0.00146	CcSEcCtD
Estradiol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000152	0.00145	CcSEcCtD
Estradiol—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00015	0.00144	CcSEcCtD
Estradiol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000149	0.00143	CcSEcCtD
Estradiol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000148	0.00142	CcSEcCtD
Estradiol—Constipation—Lisinopril—dilated cardiomyopathy	0.000147	0.00141	CcSEcCtD
Estradiol—Pain—Lisinopril—dilated cardiomyopathy	0.000147	0.00141	CcSEcCtD
Estradiol—Vomiting—Furosemide—dilated cardiomyopathy	0.000146	0.0014	CcSEcCtD
Estradiol—Rash—Furosemide—dilated cardiomyopathy	0.000145	0.00139	CcSEcCtD
Estradiol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000145	0.00139	CcSEcCtD
Estradiol—Headache—Furosemide—dilated cardiomyopathy	0.000144	0.00138	CcSEcCtD
Estradiol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000142	0.00136	CcSEcCtD
Estradiol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000141	0.00135	CcSEcCtD
Estradiol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000137	0.00131	CcSEcCtD
Estradiol—Nausea—Furosemide—dilated cardiomyopathy	0.000136	0.00131	CcSEcCtD
Estradiol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000136	0.00131	CcSEcCtD
Estradiol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000136	0.00131	CcSEcCtD
Estradiol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000127	0.00122	CcSEcCtD
Estradiol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000124	0.00119	CcSEcCtD
Estradiol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000122	0.00117	CcSEcCtD
Estradiol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000118	0.00113	CcSEcCtD
Estradiol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000114	0.00109	CcSEcCtD
Estradiol—Vomiting—Lisinopril—dilated cardiomyopathy	0.00011	0.00105	CcSEcCtD
Estradiol—Rash—Lisinopril—dilated cardiomyopathy	0.000109	0.00104	CcSEcCtD
Estradiol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000108	0.00104	CcSEcCtD
Estradiol—Headache—Lisinopril—dilated cardiomyopathy	0.000108	0.00104	CcSEcCtD
Estradiol—Nausea—Lisinopril—dilated cardiomyopathy	0.000102	0.000982	CcSEcCtD
Estradiol—UGT1A1—Metabolism—ANKRD1—dilated cardiomyopathy	4.3e-05	0.000595	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	4.29e-05	0.000594	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.28e-05	0.000592	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.27e-05	0.00059	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.25e-05	0.000588	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.22e-05	0.000584	CbGpPWpGaD
Estradiol—AOX1—Disease—NPPA—dilated cardiomyopathy	4.19e-05	0.000579	CbGpPWpGaD
Estradiol—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	4.18e-05	0.000578	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—NPPA—dilated cardiomyopathy	4.14e-05	0.000572	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.14e-05	0.000572	CbGpPWpGaD
Estradiol—ABCC10—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.1e-05	0.000567	CbGpPWpGaD
Estradiol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	4.09e-05	0.000566	CbGpPWpGaD
Estradiol—AOX1—Disease—PSEN2—dilated cardiomyopathy	4.05e-05	0.000561	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—TAZ—dilated cardiomyopathy	4.04e-05	0.000559	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—ANKRD1—dilated cardiomyopathy	4.01e-05	0.000555	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	4e-05	0.000553	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	4e-05	0.000553	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TTN—dilated cardiomyopathy	3.96e-05	0.000547	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	3.94e-05	0.000545	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	3.92e-05	0.000542	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.89e-05	0.000538	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.83e-05	0.00053	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.81e-05	0.000527	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	3.81e-05	0.000527	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	3.81e-05	0.000527	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—TAZ—dilated cardiomyopathy	3.77e-05	0.000522	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	3.72e-05	0.000514	CbGpPWpGaD
Estradiol—SLCO4A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.71e-05	0.000513	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	3.71e-05	0.000512	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.66e-05	0.000506	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	3.66e-05	0.000506	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.65e-05	0.000505	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	3.65e-05	0.000505	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—AGT—dilated cardiomyopathy	3.64e-05	0.000504	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	3.62e-05	0.0005	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	3.61e-05	0.000499	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.54e-05	0.000489	CbGpPWpGaD
Estradiol—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	3.43e-05	0.000474	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	3.43e-05	0.000474	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.43e-05	0.000474	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—SDHA—dilated cardiomyopathy	3.41e-05	0.000472	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	3.4e-05	0.00047	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	3.4e-05	0.00047	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	3.38e-05	0.000468	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	3.37e-05	0.000465	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	3.35e-05	0.000463	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.33e-05	0.000461	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.33e-05	0.000461	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.33e-05	0.00046	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—NR3C2—dilated cardiomyopathy	3.32e-05	0.00046	CbGpPWpGaD
Estradiol—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	3.2e-05	0.000442	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	3.17e-05	0.000438	CbGpPWpGaD
Estradiol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	3.13e-05	0.000433	CbGpPWpGaD
Estradiol—SLCO1C1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.11e-05	0.00043	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	3.1e-05	0.000429	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.1e-05	0.000428	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	3.08e-05	0.000425	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	3.07e-05	0.000425	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.04e-05	0.000421	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	3.03e-05	0.000419	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3e-05	0.000415	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.96e-05	0.00041	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.94e-05	0.000406	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.92e-05	0.000404	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.92e-05	0.000404	CbGpPWpGaD
Estradiol—ALB—Hemostasis—VCL—dilated cardiomyopathy	2.92e-05	0.000403	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	2.86e-05	0.000396	CbGpPWpGaD
Estradiol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	2.82e-05	0.00039	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.82e-05	0.00039	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.81e-05	0.000389	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.71e-05	0.000375	CbGpPWpGaD
Estradiol—AR—Gene Expression—NPPA—dilated cardiomyopathy	2.71e-05	0.000375	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—GPX1—dilated cardiomyopathy	2.68e-05	0.000371	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.67e-05	0.000369	CbGpPWpGaD
Estradiol—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	2.63e-05	0.000364	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	2.61e-05	0.000362	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—CD36—dilated cardiomyopathy	2.61e-05	0.000361	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	2.6e-05	0.00036	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	2.55e-05	0.000353	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	2.55e-05	0.000353	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.53e-05	0.00035	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.51e-05	0.000347	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	2.47e-05	0.000342	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	2.46e-05	0.00034	CbGpPWpGaD
Estradiol—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	2.45e-05	0.000339	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	2.43e-05	0.000336	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	2.43e-05	0.000336	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	2.42e-05	0.000335	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.39e-05	0.000331	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.39e-05	0.00033	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.38e-05	0.000329	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—AGT—dilated cardiomyopathy	2.35e-05	0.000325	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	2.33e-05	0.000323	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.33e-05	0.000322	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	2.32e-05	0.000321	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	2.32e-05	0.000321	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.29e-05	0.000317	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	2.28e-05	0.000316	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	2.26e-05	0.000313	CbGpPWpGaD
Estradiol—SLCO2B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.25e-05	0.000312	CbGpPWpGaD
Estradiol—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	2.25e-05	0.000311	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.25e-05	0.000311	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	2.22e-05	0.000307	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	2.13e-05	0.000294	CbGpPWpGaD
Estradiol—ALB—Metabolism—TAZ—dilated cardiomyopathy	2.12e-05	0.000293	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	2.1e-05	0.00029	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.1e-05	0.00029	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—NPPA—dilated cardiomyopathy	2.09e-05	0.000289	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.08e-05	0.000288	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	2.07e-05	0.000286	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.04e-05	0.000283	CbGpPWpGaD
Estradiol—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.04e-05	0.000282	CbGpPWpGaD
Estradiol—AOX1—Disease—RAC1—dilated cardiomyopathy	2.04e-05	0.000282	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.03e-05	0.00028	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	2.02e-05	0.00028	CbGpPWpGaD
Estradiol—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	2.02e-05	0.000279	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.99e-05	0.000275	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.97e-05	0.000273	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.97e-05	0.000273	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.93e-05	0.000267	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	1.93e-05	0.000266	CbGpPWpGaD
Estradiol—ALB—Metabolism—SDHA—dilated cardiomyopathy	1.91e-05	0.000265	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	1.9e-05	0.000263	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	1.88e-05	0.00026	CbGpPWpGaD
Estradiol—AOX1—Metabolism—GPX1—dilated cardiomyopathy	1.86e-05	0.000257	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.86e-05	0.000257	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.84e-05	0.000255	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.84e-05	0.000255	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.82e-05	0.000252	CbGpPWpGaD
Estradiol—AOX1—Metabolism—CD36—dilated cardiomyopathy	1.81e-05	0.000251	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.79e-05	0.000248	CbGpPWpGaD
Estradiol—SLCO1B3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.76e-05	0.000243	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.73e-05	0.00024	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.73e-05	0.00024	CbGpPWpGaD
Estradiol—SLC22A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.73e-05	0.000239	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	1.72e-05	0.000238	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.68e-05	0.000232	CbGpPWpGaD
Estradiol—AOX1—Metabolism—AGT—dilated cardiomyopathy	1.63e-05	0.000226	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.58e-05	0.000218	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.57e-05	0.000217	CbGpPWpGaD
Estradiol—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.56e-05	0.000215	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.51e-05	0.000209	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.49e-05	0.000206	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.48e-05	0.000205	CbGpPWpGaD
Estradiol—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	1.46e-05	0.000203	CbGpPWpGaD
Estradiol—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.38e-05	0.000191	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—GPX1—dilated cardiomyopathy	1.35e-05	0.000187	CbGpPWpGaD
Estradiol—AOX1—Disease—RAF1—dilated cardiomyopathy	1.35e-05	0.000187	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.34e-05	0.000185	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—GPX1—dilated cardiomyopathy	1.33e-05	0.000184	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—CD36—dilated cardiomyopathy	1.32e-05	0.000182	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.31e-05	0.000182	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—CD36—dilated cardiomyopathy	1.3e-05	0.000179	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.28e-05	0.000177	CbGpPWpGaD
Estradiol—ALB—Hemostasis—CD36—dilated cardiomyopathy	1.25e-05	0.000173	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.25e-05	0.000173	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.22e-05	0.000168	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—AGT—dilated cardiomyopathy	1.19e-05	0.000164	CbGpPWpGaD
Estradiol—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.18e-05	0.000164	CbGpPWpGaD
Estradiol—ALB—Hemostasis—RAC1—dilated cardiomyopathy	1.18e-05	0.000163	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.17e-05	0.000162	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.17e-05	0.000162	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.17e-05	0.000161	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.17e-05	0.000161	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—AGT—dilated cardiomyopathy	1.17e-05	0.000161	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.14e-05	0.000158	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.14e-05	0.000158	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.14e-05	0.000157	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.12e-05	0.000155	CbGpPWpGaD
Estradiol—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.1e-05	0.000151	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.09e-05	0.00015	CbGpPWpGaD
Estradiol—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.08e-05	0.00015	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	1.06e-05	0.000147	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.05e-05	0.000145	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.05e-05	0.000145	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	1.04e-05	0.000143	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.03e-05	0.000143	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.03e-05	0.000142	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.02e-05	0.000142	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.02e-05	0.000141	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.02e-05	0.000141	CbGpPWpGaD
Estradiol—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.01e-05	0.00014	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	9.93e-06	0.000137	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	9.74e-06	0.000135	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	9.68e-06	0.000134	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.56e-06	0.000132	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	9.33e-06	0.000129	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.31e-06	0.000129	CbGpPWpGaD
Estradiol—AOX1—Disease—EGFR—dilated cardiomyopathy	9.27e-06	0.000128	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	9.27e-06	0.000128	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.19e-06	0.000127	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	9.1e-06	0.000126	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	9.02e-06	0.000125	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.98e-06	0.000124	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	8.87e-06	0.000123	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	8.71e-06	0.00012	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.51e-06	0.000118	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	8.43e-06	0.000117	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.38e-06	0.000116	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	8.36e-06	0.000116	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	8.34e-06	0.000115	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CD36—dilated cardiomyopathy	8.21e-06	0.000114	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.17e-06	0.000113	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	8.14e-06	0.000113	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	8.12e-06	0.000112	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	8.12e-06	0.000112	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	7.98e-06	0.00011	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.96e-06	0.00011	CbGpPWpGaD
Estradiol—ALB—Hemostasis—RAF1—dilated cardiomyopathy	7.81e-06	0.000108	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	7.78e-06	0.000108	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	7.57e-06	0.000105	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—AGT—dilated cardiomyopathy	7.39e-06	0.000102	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	7.33e-06	0.000101	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.32e-06	0.000101	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	7.32e-06	0.000101	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.16e-06	9.91e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	6.82e-06	9.43e-05	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.76e-06	9.34e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RAC1—dilated cardiomyopathy	6.61e-06	9.14e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—AGT—dilated cardiomyopathy	6.32e-06	8.73e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	6.04e-06	8.35e-05	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.92e-06	8.19e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	5.88e-06	8.13e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	5.71e-06	7.89e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	5.56e-06	7.68e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	5.3e-06	7.32e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	5.23e-06	7.23e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GPX1—dilated cardiomyopathy	5.2e-06	7.19e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	5.09e-06	7.04e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CD36—dilated cardiomyopathy	5.07e-06	7e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	5e-06	6.92e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	4.67e-06	6.46e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	4.59e-06	6.34e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—AGT—dilated cardiomyopathy	4.56e-06	6.31e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.56e-06	6.3e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	4.55e-06	6.29e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.44e-06	6.14e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.38e-06	6.06e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	4.26e-06	5.89e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	4.15e-06	5.73e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	4.09e-06	5.66e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—AGT—dilated cardiomyopathy	4e-06	5.53e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	3.73e-06	5.16e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	3.64e-06	5.03e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	3.54e-06	4.9e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.19e-06	4.41e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.01e-06	4.16e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.81e-06	3.88e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.73e-06	3.78e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.46e-06	3.4e-05	CbGpPWpGaD
